U.S. Surgical reduces unfriendly bid for Circon to $17 per share.
This article was originally published in The Gray Sheet
Executive Summary
U.S. SURGICAL REDUCES UNFRIENDLY BID FOR CIRCON TO $17 PER SHARE, citing Circon's disappointing third quarter results. USSC announced Dec. 16 that it is lowering by one dollar its previously announced $18-per-share tender offer for minimally invasive urological and gynecological surgery products manufacturer Circon.